MANCHESTER, N.H. – Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery ...

Abbott has announced that its latest continuous glucose monitor, the FreeStyle Libre 3, is now covered under Medicare. Following news in April that the FDA cleared a separate handheld reader for ...

Abbott Laboratories ABT recently made its FreeStyle Libre 3 Plus sensor available to Canadians living with diabetes. This latest generation glucose monitoring device features the world's smallest ...

MISSISSAUGA, ON, July 8, 2025 /CNW/ — Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now available ...

The FreeStyle Libre 3 reader with the sensor and smartphone. [Image courtesy of Abbott] Abbott (NYSE:ABT) has made its FreeStyle Libre 3 reader available in the U.S., enabling people on Medicare to ...